Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer

Advances in Experimental Medicine and Biology

Volumn 467, Issue , 2000, Pages 217-226

  Maestroni, G J M ^a  

^a INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DYNORPHIN B; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MELATONIN;

CANCER; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HELPER CELL; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOMODULATION; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; VIRUS INFECTION;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MELATONIN; MICE; NEOPLASMS; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; VIRUS DISEASES;

BACTERIA (MICROORGANISMS);

EID: 0034469649     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (53)

1. Potential protective effects of melatonin on bone marrow of rats exposed to cytotoxic drugs
2. Interleukin-12: A new player in cytokine therapy
3. Melatonin secretion in oncological patients: Current results and methodological considerations
4. Circadian variations in the immunomodulatory role of the pineal gland
5. Protective effect of melatonin in mice infected with encephalitis viruses
6. Protective effect of melatonin in viral and bacterial infections
7. The pineal: An oncostatic gland?
8. Melatonin in oncology
9. Melatonin protects mice infected with Venezuelan equine encephalomyelitis virus
10. The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: An unexpected relationship
11. Melatonin as immunomodulator in immunodeficient mice
12. Spleen morphology and lymphoproliferative activity in short photoperiod exposed hamsters
13. Melatonin induced increase in gamma-interferon production by murine splenocytes
14. Role of pineal melatonin and melatonin-induced immuno-opioids in murine leukemogenesis
15. The clinical neuroimmunotherapeutic role of melatonin in oncology
16. Pinealectomy inhibits interleukin-2 production and natural killer activity in mice
17. Human Th1 and Th2 cells: Functional properties, mechanisms of regulation and role in disease
18. + cells
19. Signal transduction for melatonin in human lymphocytes. Involvement of a pertussis toxin-sensitive G protein
20. Melatonin-induced enhancement of antibody dependent cellular cytotoxicity
21. Mechanisms of action on the human immune system: Membrane receptors versus nuclear receptors
22. Response of CFU-GM (colony forming units for granulocytes and macrophages) from intact and pinealectomized rat bone marrow to macrophage colony stimulating factor (rGM-CSF) and human recombinant erythropoietin (rEPO)
23. The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice
24. Enkephalin-containing peptides processed from proenkephalin significantly enhance the antibody-forming cell responses to antigens
25. Endocrinology meets immunology: T lymphocytes as novel targets for melatonin
26. Age-dependent reduction in serum melatonin concentrations in healthy subjects
27. Selective effect of methoxyndoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells
28. Regulation of interleukin-2/interleukin-12 interactions by the pineal gland
29. In vivo study of the modulatory effect of the pineal hormone melatonin on interleukin-12 secretion in response to interleukin-2
30. Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer
31. Melatonin-induced T-helper cell hematopoietic cytokines resembling both interleukin-4 and dynorphin
32. The immunoneuroendocrine role of melatonin
33. Kappa-opioid receptors in marrow stroma mediate the hematopoietic effects of melatonin-induced opioid cytokines
34. Beta-endorphin and dynorphin mimic the circadian immunoenhancing and anti-stress effects of melatonin
35. + cells to release opioid agonist(s) with immunoenhancing and anti-stress properties
36. Anti-stress role of the melatonin-immuno-opioid network. Evidence for a physiological mechanism involving T cell-derived, immunoreactive β-endorphin and enkephalin binding to thymic opioid receptors
37. Melatonin in relation to the immune system
38. Melatonin in human breast cancer tissue: Association with nuclear grade and estrogen receptor status
39. Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4
40. Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonize the imunosuppressive effect of corticosterone
41. Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism
42. Hematopoietic rescue via T-cell-dependent, endogenous GM-CSF by the pineal neurohormone melatonin in tumor bearing mice
43. Biochemical and functional characterization of melatonin-induced opioids in spleen and bone marrow T-helper cells
44. Pharmacological control of the hormonally modulated immune response
45. Activation of human monocytes by the pineal neurohormone melatonin
46. Melatonin as biological response modifier in cancer patients
47. Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II study
48. Modulation of antibody-dependent cellular cytotoxicity by pineal gland
49. Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation
50. Evidence for a direct action of melatonin on the immune system
51. Melatonin administration attenuates depressed immune functions trauma-hemorrhage
52. Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2
53. Melatonin: History, biosynthesis, and assay methodology